NFO Alert: Bajaj Allianz Life Launches ‘Focused 25 Fund’ For Long-Term Wealth


Last Updated:

Bajaj Allianz Life launches the NFO for Bajaj Allianz Life Focused 25 Fund, aiming for long-term capital growth with up to 25 large-cap stocks. NFO ends March 20, 2025.

New NFO Alert

New NFO Alert

Bajaj Allianz Life, one of India’s leading private life insurers, has announced the launch of its New Fund Offer (NFO) – Bajaj Allianz Life Focused 25 Fund. The fund will be available along with its ULIP products and is designed to achieve long-term capital appreciation through a concentrated portfolio of up to 25 stocks across market capitalizations, with a predominant focus on large-cap companies, along with a life cover. The fund is benchmarked against the Nifty 100 Index, ensuring alignment with India’s top-performing companies. This NFO for Bajaj Allianz Life ‘Focused 25 Fund’ ends on 20th March, 2025.

With India’s economy poised for robust growth, customers are seeking high-quality, actively managed portfolios that balance risk and reward. In this evolving investment landscape, Bajaj Allianz Life Focused 25 Fund aims to cater to long-term wealth creators by maintaining a concentrated, high-conviction portfolio of select businesses with strong fundamentals, and sustainable growth potential—going beyond traditional diversified strategies to unlock superior risk adjusted returns.

The fund will be actively managed to capitalize on market opportunities and navigate changing market conditions. Stock selection will be based on a well-defined investment philosophy and stock selection framework, emphasizing companies with strong competitive advantages, acceptable levels of corporate governance, and attractive valuations.

Speaking on the launch of the new fund, Mr. Srinivas Rao Ravuri, Chief Investment Officer, Bajaj Allianz Life Insurance, said, “With Bajaj Allianz Life Focused 25 Fund, we aim to offer investors a high-conviction strategy that capitalizes on India’s strong growth trajectory. Our disciplined, research-backed approach will enable investors to participate in the success of fundamentally sound strong companies, ensuring sustainable wealth creation over the long term. The fund will invest in up to 25 carefully selected stocks, primarily in large caps, while remaining sector- and market-cap-agnostic for dynamic allocation.”

With a focused portfolio of well-chosen stocks, Bajaj Allianz life ULIP products with underlying  Bajaj Allianz Life Focused 25 Fund is intended for investors with a very -high risk tolerance who want to build wealth over the long run.

About Bajaj Allianz Life Insurance

Bajaj Allianz Life Insurance is one of India’s leading and fastest growing private life insurers. The Company is a partnership between two powerful and successful entities in their own right – Bajaj Finserv Limited, one of India’s most diversified non-banking financial institutions and Allianz SE, one of the world’s leading asset manager and insurer. The Company commenced its journey in 2001, and today delivers its promise of Life Goals. DONE. through innovative value-packed insurance products that are backed by a robust tech and digital ecosystem. Bajaj Allianz Life Insurance continues its journey of transformation through its products and tech enabled state-of-the-art services to enhance customer delight.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Does Apple Cider Vinegar Prevent Glucose Spike Before Meals? Heres What You Should Know

In today's fast-paced world, we are always looking for natural remedies to support our health and well-being. From superfoods to herbal drinks, every ingredient...

Equity Fund Inflows Drop 26% To Rs 29,303 Cr In February Due to Market Volatility: AMFI

Last Updated:March 12, 2025, 14:16 ISTEquity fund inflows dropped 26.17 percent to Rs 29,303 crore in February from Rs 39,687 crore in January due...

Males ‘more impacted by mother smoking during pregnancy’

Ken BanksBBC Scotland, AberdeenGetty ImagesFelix Grassmann, professor of epidemiology and biostatistics at the Health and Medical University in Germany, co-led the research."Most research has...

Follow us

653FansLike
201FollowersFollow
467SubscribersSubscribe

Most Popular